Strong figures boosted by Moderna vaccine CDMO
Results were better than expected on a slightly better sales figure (+4%) and better margins despite a raw materials headwind. Heparins grew 15% thanks to Hibor outside Spain, while the main contributor to sales was the services business (+179%), which registered the first impact from the Moderna vaccine contract development and manufacturing organisation (CDMO). Gross margin did not improve, as expected, due to the growing raw material prices of h ....
13 May 2021
Strong figures and positive outlook
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Strong figures and positive outlook
Laboratorios Farmaceuticos Rovi, S.A. (ROVI:MCE), 0 | Laboratorios Farmaceuticos Rovi, S.A. (0ILL:LON), 0
- Published:
13 May 2021 -
Author:
Ruiz Francisco FR -
Pages:
9
Strong figures boosted by Moderna vaccine CDMO
Results were better than expected on a slightly better sales figure (+4%) and better margins despite a raw materials headwind. Heparins grew 15% thanks to Hibor outside Spain, while the main contributor to sales was the services business (+179%), which registered the first impact from the Moderna vaccine contract development and manufacturing organisation (CDMO). Gross margin did not improve, as expected, due to the growing raw material prices of h ....